Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth

Cited by (215)

Items 201–215 of 215

1. Structural basis for activation of glutaminase
   Chen-Jun Guo, Zi-Xuan Wang, Ji‐Long Liu · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
2. Oncometabolites in tumor cells: Current technique and procedure
   Seema Nayak, Anupam Kumar Sriwastava · 2024 · Elsevier eBooks
3. Identification of cuproptosis-related gene CDKN2A as a molecular diagnostic target in gastric carcinoma based on transcriptomic data
   Guo Chen, Wenli Zhang, Di Wei, Zeng Li, Jun Lü, Wenying Liu, Lei Wang, Zifan Lu · 2025 · Research Square
4. Uncovering the Heterogeneity of Signaling Pathways in Skin Cutaneous Melanoma: Insights into Prognostic Values and Immune Interactions
   Yufang Liu, Chunyan Li, Weiwei Deng · 2025 · Clinical Cosmetic and Investigational Dermatology
5. New Mechanism of Action of Rapalogs : Transcriptional Regulation of TRIB3 and Alteration of Pre-mRNA Splicing
   Bojana Stefanovska · 2019 · theses.fr (ABES)
6. Biochemical characterization of mTORC1 regulation by glutamine metabolism
   Clément Bodineau · 2020 · theses.fr (ABES)
7. Physapubescin B From Physalis: A Food‐Derived Withanolide for Cancer Chemoprevention and Nutraceutical Development
   Wojciech Koch, Katarzyna Stępnik, Anna Wawruszak, Estera Okoń, Agata Jarząb, Katarzyna Gaweł‐Bęben, Magdalena Michalak-Tomczyk, Jacek Jachuła, Magdalena Zdziebło, Paweł Helon et al. · 2026 · eFood
8. Mechanistic target of rapamycin complex (mTORC)-glutamine axis in cancer: Mechanistic crosstalk, therapeutic resistance, and clinical opportunities
   Subha Ranjan Das, Igor E. Koman, Elimelech Nesher · 2026 · Cancer Pathogenesis and Therapy
9. Lung cancer metabolism: a dynamic and adaptive network
   Sara Gholamhosseinian Najjar, Christian Frezza · 2026 · Cellular and Molecular Life Sciences
10. BindingDB Entry 50013553: Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer.
    BindingDB · 2022 · UC San Diego
11. BindingDB Entry 50008027: Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.
    BindingDB · 2021 · UC San Diego
12. BindingDB Entry 50009703: Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.
    BindingDB · 2021 · UC San Diego
13. BindingDB Entry 50006778: Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase.
    BindingDB · 2021 · UC San Diego
14. Computational identification of dioxin response elements in human, mouse, and rat genomes
    Rance Nault, Tim R. Zacharewski · 2019 · Harvard Dataverse
15. BindingDB Entry 50047602: Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold.
    BindingDB · 2017 · UC San Diego